GLP-1 Peptide Comparison | Research Guide | Updated March 2026 The GLP-1 receptor agonist class has become one of the most actively researched areas in metabolic science. What began with semaglutide — the compound behind Ozempic and Wegovy — has rapidly expanded into a new generation of multi-receptor peptides that are producing weight loss results […]
Blog
Semaglutide & Ozempic for Weight Loss:What the Science Actually Says
GLP-1 Pharmacology & Obesity Treatment | 10-Minute Read | Updated March 2026 Few drugs in modern pharmacological history have generated the cultural and clinical earthquake caused by semaglutide. Since its first approval for type 2 diabetes under the brand name Ozempic, and its subsequent approval for obesity management as Wegovy, semaglutide has become one of […]